Vicarious Surgical Inc. (NYSE:RBOT) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET

Company Participants

Kaitlyn Brosco - Investor Relations

Adam Sachs - Chief Executive Officer

Bill Kelly - Chief Financial Officer

Conference Call Participants

Ryan Zimmerman - BTIG

Adam Maeder - Piper Sandler

Josh Jennings - TD Cohen

Caitlin Cronin - Canaccord Genuity

Operator

Good afternoon, and welcome to Vicarious Surgical's Third Quarter 2023 Earnings Conference Call. My name is Kate, and I’ll be your operator for today's call. At this time all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Kaitlyn Brosco with Vicarious Surgical for a few introductory comments.

Kaitlyn Brosco

Thanks Kate and thank you all for participating in today's call. Earlier today Vicarious Surgical released financial results for the three months ended September 30, 2023. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.

All forward-looking statements, including without limitation, those relating to obtaining approval for the Vicarious Surgical System and timing for any such approval, our operating trends and future financial performance, expense management, market opportunity and commercialization are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

For a list and description of the risks and uncertainties associated with our business, please refer to the risk factors set forth in our Securities and Exchange Commission filings, including our most recent Form 10-K and Form 10-Q.

This conference call contains time-sensitive information that is accurate only as of the live broadcast today, November 13, 2023. Vicarious Surgical disclaims any intention or obligation, except required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.